Abstract Details

Title MRI Approaches for Specific Targeting of PrP[sup]Sc[/sup] in the Spleen of Prion Infected Presymptomatic Subjects

Topic Infections/AIDS/Prion Disease

Presentation(s) (-)

Poster/Presentation
Number 007

Background

Objective

Design/Methods

Results

Conclusions

Authors/Disclosures
Erin Furr-Stimming, MD, FAAN (University of Texas Health Science Center-Houston)	Dr. Furr-Stimming has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Teva Pharmaceuticals. Dr. Furr-Stimming has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Michael J. Fox Foundation. Dr. Furr-Stimming has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Medscape. Dr. Furr-Stimming has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Teva Pharmaceuticals. The institution of Dr. Furr-Stimming has received research support from Huntington's Disease Society of America. The institution of Dr. Furr-Stimming has received research support from Roche/Genetech. The institution of Dr. Furr-Stimming has received research support from Uniqure. The institution of Dr. Furr-Stimming has received research support from CHDI. The institution of Dr. Furr-Stimming has received research support from Huntington Study Group/Neurocrine. The institution of Dr. Furr-Stimming has received research support from NIH/University of Iowa. The institution of Dr. Furr-Stimming has received research support from Sage Therapeutics. Dr. Furr-Stimming has received publishing royalties from a publication relating to health care.
	No disclosure on file
	No disclosure on file
	No disclosure on file
	No disclosure on file
	No disclosure on file
Bindi Patel	No disclosure on file
	No disclosure on file
	No disclosure on file
	No disclosure on file
Mark Richardson, MD, MRCP (Institute of Psychiatry)	The institution of Dr. Richardson has received research support from Medical Research Council UK. The institution of Dr. Richardson has received research support from Epilepsy Research UK. The institution of Dr. Richardson has received research support from GW Pharma. The institution of Dr. Richardson has received research support from European Commission. The institution of Dr. Richardson has received research support from Autifony Therapeutics . The institution of Dr. Richardson has received research support from Epilepsy Foundation of America . Dr. Richardson has received intellectual property interests from a discovery or technology relating to health care.
	No disclosure on file
	No disclosure on file
Hugo J. Bellen, PhD (BAYLOR COLLEGE OF MEDICINE)	No disclosure on file
	No disclosure on file
	No disclosure on file
	No disclosure on file
	No disclosure on file
	No disclosure on file
Sheng Zhang	No disclosure on file
	No disclosure on file